A blueprint for robotic navigation: pre-clinical simulation for transanal total mesorectal excision (taTME)

Atallah, S.; Zenoni, S.; Kelly, Justin; Tilahun, Yaphet; Monson, J. R. T.

doi:10.1007/s10151-016-1511-x

Cited by 11 publications

(3 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Real-time stereotactic navigation may be useful in enhancing precision and the full understanding of the complex anatomies, during robotic TME [41]. Atallah et al described real-time stereotactic navigation using the da Vinci Ⓡ Xi platform with the TilePro Ⓡ interface, as well as a blueprint for robotic navigation in TaTME with real-time navigation combining the robotic and Stryker Navigation Systems [42]. We expect that robotic systems and surgical data platforms based on artificial intelligence will complement each other to help surgeons provide more optimized patient care.…”

Section: Robotic Surgery Using Other Advanced and Incorporated Techno...mentioning

confidence: 99%

Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version

Bae

2022

J Anus Rectum Colon

View full text Add to dashboard Cite

Robotic surgical systems were created in part to solve several constraints of laparoscopic surgery and offer technical advantages. With a substantial body of evidence that demonstrates its efficacy in the treatment of rectal cancer, robotic surgery will soon become another conventional treatment. However, further investigations and randomized trials focusing on primary endpoints are needed to establish some advantages for robot-assisted colon surgery. Da Vinci Single-Site Ⓡ and SP Ⓡ platforms were developed to overcome the shortcomings of single-port laparoscopic surgery. Despite the currently insufficient evidence, it appears that the SP platform addresses many of the limitations of single-port transabdominal or transanal surgery. Robotic transanal minimally invasive surgery and total mesorectal excision were developed to overcome some of the limitations of conventional platforms, using wristed instrumentation to enhance dexterity and ergonomics. Studies on the effectiveness and viability of this novel approach are ongoing. The near-infrared fluorescence technique, real-time stereotactic navigation technology, and other surgical data platforms based on artificial intelligence incorporated into the robotic system will play an important role in improving outcomes. Robotic systems for advanced colorectal cancer offer technical advantages for complex and precise surgeries. If the cost of robotic surgery is reduced by expanding its indications and enhancing competition among different robotic platforms, it will provide clinical benefits to more patients and reduce social healthcare costs.

show abstract

Section: Robotic Surgery Using Other Advanced and Incorporated Techno...mentioning

confidence: 99%

Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version

Bae

2022

J Anus Rectum Colon

View full text Add to dashboard Cite

show abstract

“…The preclinical development of different systems has been reported in different settings. Senhance® reported its initial development in a dry laboratory [28,59,62,63], Revo-I and Senhance® performed preclinical studies using porcine models [18,21,50,95,96], Versius® was developed using porcine and cadaveric models [97][98][99][100][101][102][103][104], EDGE SP1000 reported one study done in a porcine model [83], Flex® used cadaveric and ex vivo models [85]; EDGE and Hominis® did not report any information on this topic.…”

Section: Studiesmentioning

confidence: 99%

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Farinha¹,

Sarchi²,

Paciotti³

et al. 2022

Clin. Exp. Obstet. Gynecol.

View full text Add to dashboard Cite

Objective: To summarize the scientific published literature on new robotic platforms with potential use in gynecology and review their evolution from inception until the present day. The goal was to describe the current characteristics and possible prospects of these platforms. Mechanism: A non-systematic search of PubMed, Cochrane Library Central, EMBASE, MEDLINE, and Scopus databases was conducted to identify scientific literature on new robotic platforms and review their evolution from inception until January 2022. Only English-language publications were included in this analysis. The following keywords were used: "new robotic platforms", "robot", "Revo-I", "Versius®", "Senhance®", "Single-Site", "Single-Port", "Multi-Port", "EDGE SP1000", "Flex®", and "Hominis®". Abstract reviews were conducted to determine the relevance of the review aims. Full-text analysis of all relevant English-language original articles was subsequently performed by one author (R.F.) and summarized after discussion with an independent third party (L.S., M.P.). No formal quality assessment of the included studies was conducted. Findings in brief: The Da Vinci robotic system is the leading platform in the robotic surgery market. Other new platforms have published peer-reviewed articles in the field of gynecology. Senhance® and Da Vinci SP® have the most substantial proof of their capacity to perform multi-incision and single-incision robotic surgery, respectively. Hominis® has the potential to play a major role in ultra-minimally invasive and scarless approaches. Conclusions: The significant advantages of Intuitive's robots justify their worldwide dissemination. However, their drawbacks have motivated other companies to develop innovative solutions. Our research shows that the majority of these new platforms are still at the beginning of their technical and scientific validation but seem very promising.

show abstract

“…Navigation may be useful for R-TaTME to enhance the precision of the movements and to fully understand the complex anatomies[ 63 ]. Blueprint for R-TaTME navigation was described by combining the da Vinci Xi ® Surgical System and the Stryker Navigation System, with the GelPOINT ® Platform[ 64 ]. More recently, real-time stereotactic navigation with the da Vinci ® Xi platform via the TilePro ® interface has been reported[ 65 ].…”

Section: Future Perspectivesmentioning

confidence: 99%

Robotic transanal total mesorectal excision: Is the future now?

Sebastián-Tomás¹,

Martínez-Pérez²,

Martínez-López³

et al. 2021

WJGS

View full text Add to dashboard Cite

Total mesorectal excision (TME) is the standard surgical treatment for the curative radical resection of rectal cancers. Minimally invasive TME has been gaining ground favored by the continuous technological advancements. New procedures, such as transanal TME (TaTME), have been introduced to overcome some technical limitations, especially in low rectal tumors, obese patients, and/or narrow pelvis. The earliest TaTME reports showed promising results when compared with the conventional laparoscopic TME. However, recent publications raised concerns regarding the high rates of anastomotic leaks or local recurrences observed in national series. Robotic TaTME (R-TaTME) has been proposed as a novel technique incorporating the potential benefits of a perineal dissection together with precise control of the distal margins, and also offers all those advantages provided by the robotic technology in terms of improved precision and dexterity. Encouraging short-term results have been reported for R-TaTME, but further studies are needed to assess the real role of the new technique in the long-term oncological or functional outcomes. The present review aims to provide a general overview of R-TaTME by analyzing the body of the available literature, with a special focus on the potential benefits, harms, and future perspectives for this novel approach.

show abstract

A blueprint for robotic navigation: pre-clinical simulation for transanal total mesorectal excision (taTME)

Cited by 11 publications

References 10 publications

Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version

Current Status and Future of Robotic Surgery for Colorectal Cancer-An English Version

New Robotic Platforms for Gynecology. Are We Achieving One of the Golden Goals?

Robotic transanal total mesorectal excision: Is the future now?

Contact Info

Product

Resources

About